Latest filing published 15 Jun 2026 for Isofol Medical AB (publ), €8,441.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Petter Segelman Lindqvist: trading record in brief
Petter Segelman Lindqvist is a declared insider of Isofol Medical AB (publ) (chief executive), with filings sourced from Finansinspektionen. Between 19 June 2025 and 15 June 2026, the trades on record add up to 3 filings.
On the open market, the record shows 1 purchase worth €8,441 and 1 sale worth €271. The net balance comes to €8,170 on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and no sales.
Most recently, on 15 June 2026, the filings show an open-market purchase worth €8,441 in Isofol Medical AB (publ). Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Petter Segelman Lindqvist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ SEK 0.092378.3% of flowTeckningsoptionFI:csv-91908161023c21b62feeCanonical exit: 13 Sept 2026 (T+90)
- 2,412 shares@ SEK 9.6019.1% of flowBTU (betald tecknad unit)ISIN SE0025197536FI:A003Q427-1
- 33,408 shares@ SEK 0.092.5% of flowTeckningsrätt/UniträttISIN SE0025197528FI:A003Q152-1
3 of 3 declarations